References
- Hefnawi F, Toppozada M, Rizk M, Shaaban M, Ei Said A M, Mustafa A F M. NORPLANT® clinical studies in Egypt. Long-acting contraceptive delivery systems, Gl Zatuchni, A Goldsmith, J Shelton, J J Sciarra. Harper & Row Publishers, Philadelphia 1984; 471–81
- Shaaban M M, Salah M, Zarzour A, Abdullah S. A prospective study of NORPLANT® and the TCu 380 Ag IUD in Assiut Egypt. Stud Fam Plann 1983; 14: 163–9
- Shaaban M M, Salah M. A two-year experience with NORPLANT® implants in Assiut. Egypt Contraception 1984; 29: 335–43
- Salah M, Abdel-Ghaffar A, Abo-Eloyoun M, Shaaban M M. Five-year experience with NORPLANT® in Assiut, Egypt. Contraception 1987; 35: 543–50
- Sivin I. International experience with NORPLANT® and NORPLANT®-2 contraceptives. Stud Fam Plann 1988; 19: 81–94
- Population Reports. Hormonal contraception: new long-acting methods 1987; 15(1)
- Shaaban M M, Elwan S I, Abdel-Aleem H, et al. Effect of subdermal levonorgestrel contraceptive implants NORPLANT® on serum lipids. Contraception 1984; 30: 413–9
- Shaaban M M, Elwan S I, Ei-Sharkawy M M, Farghaly A S. Effect of subdermal levonorgestrel contraceptive implants, NORPLANT® on liver functions. Contraception 1984; 30: 407–12
- Shaaban M M, Elwan S I, Ei-Kabsh M Y, Farghaly S A, Thabet N. Effect of levonorgestrel contraceptive implants, NORPLANT® on blood coagulation. Contraception 1984; 30: 421–30
- Shaaban M M, Salem H T, Abdullah K H. Influence of levonorgestrel contraceptive implants NORPLANT®, initiated early postpartum upon lactation and infant growth. Contraception 1985; 32: 623–35
- Shaaban M M. Contraception with progestogens and progesterone during lactation. J Steroid Biochem Molec Biol 1991; 40: 705–10
- Zimmerman M, Haffey J, Crane E, et al. Assessing the acceptability of NORPLANT® implants in four countries: findings from focus group research. Stud Fam Plann 1990; 21: 92–103